ACHILLION PHARMACEUTICALS INC Diluted Shares Outstanding (Weighted Average)
ACHILLION PHARMACEUTICALS INC reported Diluted Shares Outstanding (Weighted Average) of 136.69 million shares for the 3-month period ending 2016-12-31, per its 10-K filed 2017-02-23.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2017-02-23
- ACHILLION PHARMACEUTICALS INC weighted average number of shares outstanding, diluted for the quarter ending 2016-12-31 was 136.69M shares, a 2.69% decline year-over-year.
- ACHILLION PHARMACEUTICALS INC weighted average number of shares outstanding, diluted for the quarter ending 2016-09-30 was 136.68M shares, a 2.39% decline year-over-year.
- ACHILLION PHARMACEUTICALS INC weighted average number of shares outstanding, diluted for the quarter ending 2016-06-30 was 136.68M shares, a 16.06% increase year-over-year.
- ACHILLION PHARMACEUTICALS INC weighted average number of shares outstanding, diluted for the quarter ending 2016-03-31 was 136.64M shares, a 22.88% increase year-over-year.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2016-12-31 | 136.69M shares 10-K · filed 2017-02-23 | 136.69M shares derived: average of 2 quarters · filed 2017-02-23 | 136.68M shares derived: average of 3 quarters · filed 2017-02-23 | 136.67M shares derived: average of 4 quarters · filed 2017-02-23 |
| 2016-09-30 | 136.68M shares 10-K · filed 2017-02-23 | 136.68M shares derived: average of 2 quarters · filed 2017-02-23 | 136.65M shares 10-Q · filed 2016-11-03 | 137.62M shares derived: average of 4 quarters · filed 2017-02-23 |
| 2016-06-30 | 136.68M shares 10-K · filed 2017-02-23 | 136.66M shares derived: average of 2 quarters · filed 2017-02-23 | 137.93M shares derived: average of 3 quarters · filed 2017-02-23 | 138.45M shares derived: average of 4 quarters · filed 2017-02-23 |
| 2016-03-31 | 136.64M shares 10-K · filed 2017-02-23 | 138.56M shares derived: average of 2 quarters · filed 2017-02-23 | 139.05M shares derived: average of 3 quarters · filed 2017-02-23 | 133.73M shares derived: average of 4 quarters · filed 2017-02-23 |
| 2015-12-31 | 140.47M shares 10-K · filed 2017-02-23 | 140.25M shares derived: average of 2 quarters · filed 2017-02-23 | 132.76M shares derived: average of 3 quarters · filed 2017-02-23 | 127.37M shares derived: average of 4 quarters · filed 2017-02-23 |
| 2015-09-30 | 140.02M shares 10-Q · filed 2016-11-03 | 128.90M shares derived: average of 2 quarters · filed 2017-02-23 | 121.90M shares 10-Q · filed 2016-11-03 | 117.39M shares derived: average of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | 117.77M shares 10-K · filed 2017-02-23 | 114.49M shares derived: average of 2 quarters · filed 2017-02-23 | 109.85M shares derived: average of 3 quarters · filed 2017-02-23 | 107.15M shares derived: average of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | 111.20M shares 10-K · filed 2017-02-23 | 105.89M shares derived: average of 2 quarters · filed 2017-02-23 | 103.60M shares derived: average of 3 quarters · filed 2017-02-23 | 101.96M shares derived: average of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | 100.58M shares 10-K · filed 2016-02-25 | 99.81M shares derived: average of 2 quarters · filed 2016-02-25 | 98.88M shares derived: average of 3 quarters · filed 2016-02-25 | 98.35M shares derived: average of 4 quarters · filed 2016-02-25 |
| 2014-09-30 | 99.03M shares 10-K · filed 2016-02-25 | 98.02M shares derived: average of 2 quarters · filed 2016-02-25 | 97.62M shares 10-Q · filed 2015-11-05 | |
| 2014-06-30 | 97.02M shares 10-K · filed 2016-02-25 | 96.90M shares derived: average of 2 quarters · filed 2016-02-25 | ||
| 2014-03-31 | 96.79M shares 10-K · filed 2016-02-25 |